Neupro 2 mg/24 h transdermal patch

Safety of rotigotine in patients with autosomal dominant polycystic kidney disease - ETERNAL-PKD

Effects of Dopaminergic Therapy in Patients with Alzheimer's Disease: A 24 weeks prospective, randomized, double-blind, placebo-controlled, parallel group, international, multi-center phase III study evaluating efficacy and safety of rotigotine 4mg/24 hrs in combination with rivastigmine 9.5 mg/24 hrs in mild to moderate Alzheimer's disease patients.